Literature DB >> 19020754

Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4.

Lara Tickenbrock1, Sina Hehn, Bülent Sargin, Chunaram Choudhary, Nicole Bäumer, Horst Buerger, Bernd Schulte, Oliver Müller, Wolfgang E Berdel, Carsten Müller-Tidow, Hubert Serve.   

Abstract

Wnt signalling regulates proliferation, self renewal and cell fate. Aberrant Wnt signalling is thought to contribute to AML pathogenesis by enhancing self renewal. Herein, we provide evidence for increased expression of Frizzled-4, a receptor for Wnt ligands, in primary AML blasts compared to normal bone marrow on the protein level. In addition, Frizzled-4 is highly expressed in human CD34 positive cells as well as in lineage negative sorted mouse bone marrow cells. Functionally, Frizzled-4 expression modulates apoptosis and enhances Wnt3a induced beta-catenin stability in myeloid progenitor cells. Frizzled-4-dependent beta-catenin stabilization is dkk-1 sensitive, implicating a specific Wnt-ligand/Frizzled-receptor interaction. These findings indicate enhanced sensitivity of AML blasts for Wnt-ligands and suggest an additional mechanism of Wnt signalling activation in the pathogenesis of AML.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020754

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  13 in total

1.  β-Arrestin2 mediates the initiation and progression of myeloid leukemia.

Authors:  Mark Fereshteh; Takahiro Ito; Jeffrey J Kovacs; Chen Zhao; Hyog Young Kwon; Valerie Tornini; Takaaki Konuma; Minyong Chen; Robert J Lefkowitz; Tannishtha Reya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-05       Impact factor: 11.205

2.  Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients.

Authors:  Angela Coscio; David W Chang; Jack A Roth; Yuanqing Ye; Jian Gu; Ping Yang; Xifeng Wu
Journal:  Carcinogenesis       Date:  2014-02-11       Impact factor: 4.944

3.  A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties.

Authors:  Zvezdan Pavlovic; Jarrett J Adams; Levi L Blazer; Amandeep K Gakhal; Nick Jarvik; Zachary Steinhart; Mélanie Robitaille; Keith Mascall; James Pan; Stephane Angers; Jason Moffat; Sachdev S Sidhu
Journal:  MAbs       Date:  2018-09-25       Impact factor: 5.857

4.  Peripheral T-lymphocytes express WNT7A and its restoration in leukemia-derived lymphoblasts inhibits cell proliferation.

Authors:  Alejandra B Ochoa-Hernández; Moisés Ramos-Solano; Ivan D Meza-Canales; Beatriz García-Castro; Mónica A Rosales-Reynoso; Judith A Rosales-Aviña; Esperanza Barrera-Chairez; Pablo C Ortíz-Lazareno; Georgina Hernández-Flores; Alejandro Bravo-Cuellar; Luis F Jave-Suarez; Patricio Barros-Núñez; Adriana Aguilar-Lemarroy
Journal:  BMC Cancer       Date:  2012-02-07       Impact factor: 4.430

5.  Cell polarity, epithelial-mesenchymal transition, and cell-fate decision gene expression in ductal carcinoma in situ.

Authors:  Danila Coradini; Patrizia Boracchi; Federico Ambrogi; Elia Biganzoli; Saro Oriana
Journal:  Int J Surg Oncol       Date:  2012-04-02

Review 6.  Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.

Authors:  Roya Tabatabai; Yuliya Linhares; David Bolos; Monica Mita; Alain Mita
Journal:  Target Oncol       Date:  2017-10       Impact factor: 4.864

7.  Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.

Authors:  Abdullah Aljedai; Anne-Marie Buckle; Prashant Hiwarkar; Farhatullah Syed
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

8.  Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia.

Authors:  Francesca Lazzaroni; Luca Del Giacco; Daniele Biasci; Mauro Turrini; Laura Prosperi; Roberto Brusamolino; Roberto Cairoli; Alessandro Beghini
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

Review 9.  Frizzled Receptors as Potential Therapeutic Targets in Human Cancers.

Authors:  Chui-Mian Zeng; Zhe Chen; Li Fu
Journal:  Int J Mol Sci       Date:  2018-05-22       Impact factor: 5.923

10.  WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.

Authors:  Ren-Jun Hsu; Jar-Yi Ho; Tai-Lung Cha; Dah-Shyong Yu; Chieh-Lin Wu; Wei-Ping Huang; Pauling Chu; Ying-Hsin Chen; Jiann-Torng Chen; Cheng-Ping Yu
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.